Medica Group - MGP Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 211
+0 (0.00%)

This chart shows the closing price for MGP by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Medica Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MGP and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MGP

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Medica Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 211.

This chart shows the closing price for MGP for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Medica Group. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/20/2023Panmure GordonInitiated CoverageBuyGBX 187
8/18/2021Numis SecuritiesReiterated RatingBuyGBX 210
7/22/2021Liberum CapitalReiterated RatingBuyGBX 235
6/15/2021Numis SecuritiesReiterated RatingAddGBX 180
5/14/2021Credit Suisse GroupReiterated RatingNeutralGBX 220
5/14/2021Liberum CapitalReiterated RatingBuyGBX 220
5/12/2021Numis SecuritiesReiterated RatingAddGBX 180
7/8/2020Peel HuntReiterated RatingHold
7/2/2020Peel HuntReiterated RatingHold
6/3/2020Peel HuntReiterated RatingHold
5/20/2020Peel HuntReiterated RatingHold
5/1/2020Peel HuntReiterated RatingHold
4/15/2020Peel HuntUpgradeHoldGBX 126 ➝ GBX 112
4/7/2020Peel HuntReiterated RatingReduce
3/30/2020Peel HuntReiterated RatingReduce
3/23/2020Peel HuntReiterated RatingReduce
3/11/2020Peel HuntReiterated RatingReduce
3/5/2020Peel HuntReiterated RatingReduce
2/5/2020Peel HuntReiterated RatingReduce
1/27/2020Peel HuntDowngradeReduce
1/23/2020Peel HuntReiterated RatingHoldGBX 126
1/23/2020Peel HuntReiterated RatingHoldGBX 126
1/10/2020Peel HuntReiterated RatingHold
12/5/2019Peel HuntReiterated RatingHold
11/4/2019Peel HuntReiterated RatingHold
9/9/2019Peel HuntReiterated RatingHold
9/2/2019Peel HuntReiterated RatingHoldGBX 126
8/29/2019Peel HuntUpgradeHoldGBX 126
8/1/2019Peel HuntReiterated RatingReduce
7/22/2019Peel HuntReiterated RatingReduce
7/3/2019Peel HuntReiterated RatingReduce
6/18/2019Peel HuntLower TargetReduceGBX 143 ➝ GBX 126
6/4/2019Peel HuntReiterated RatingReduce
5/22/2019Peel HuntReiterated RatingReduce
5/13/2019Peel HuntInitiated CoverageReduceGBX 143
3/25/2019Numis SecuritiesReiterated RatingBuyGBX 165
(Data available from 2/24/2019 forward)

News Sentiment Rating

0.46 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/29/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/28/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/26/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/25/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/24/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Medica Group logo
Medica Group Plc, together with its subsidiaries, provides teleradiology reporting services to NHS and private healthcare providers in the United Kingdom, Ireland, and the United States. It offers Elective, a reporting service; NightHawk, an out of hours emergency reporting service; and managed, imaging, diabetic retinopathy screening, and teleophthalmology services. Medica Group Plc was founded in 2004 and is headquartered in Hastings, the United Kingdom.
Read More

Today's Range

Now: GBX 211
Low: 211
High: 211

50 Day Range

MA: GBX 211
Low: 211
High: 211

52 Week Range

Now: GBX 211
Low: 118.25
High: 215

Volume

1,566,518 shs

Average Volume

867,305 shs

Market Capitalization

£259.85 million

P/E Ratio

3,516.67

Dividend Yield

1.33%

Beta

1.1

Frequently Asked Questions

What sell-side analysts currently cover shares of Medica Group?

The following Wall Street sell-side analysts have issued reports on Medica Group in the last twelve months:
View the latest analyst ratings for MGP.

What is the current price target for Medica Group?

0 Wall Street analysts have set twelve-month price targets for Medica Group in the last year. has the lowest price target set, forecasting a price of £100,000 for Medica Group in the next year.
View the latest price targets for MGP.

What is the current consensus analyst rating for Medica Group?

Medica Group currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MGP.

What other companies compete with Medica Group?

How do I contact Medica Group's investor relations team?

Medica Group's physical mailing address is 1980 Festival Plaza Dr Ste 750, Las Vegas, Nevada 89135-2958. The company's listed phone number is 44 33 3311 1222. The official website for Medica Group is www.medicagroup.co.uk. Learn More about contacing Medica Group investor relations.